Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Genetix Biotherapeutics Inc.'s investors include RA Capital Management, ARCH Venture Partners, Third Rock Ventures, Forbion Capital Partners, Hercules Capital.
Genetix Biotherapeutics Inc. is headquartered in Somerville, United States.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Genetix Biotherapeutics Inc. is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genetix Biotherapeutics Inc. — Funding & Investors." VCBacked, February 21, 2025, https://www.vcbacked.co/company/genetix-biotherapeutics-inc. Accessed September 3, 2026.
VCBacked. (2025). Genetix Biotherapeutics Inc. — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/genetix-biotherapeutics-inc
{{cite web |title=Genetix Biotherapeutics Inc. — Funding & Investors |url=https://www.vcbacked.co/company/genetix-biotherapeutics-inc |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated